(
a) Fiber tip placement in the striatum for D1-ChR2 (blue), D1-eYFP (white) and D1-NR1 (red) cohorts shown in
Figure 1 (left), and intracellular slice recording from a dMSN expressing ChR2 from a D1-Cre x NR1f/f mouse injected with DIO-ChR2, showing absence of NMDA receptor-dependent current at +40 mV. (
b) Fiber tip placement in the SNr for Arch3 (green) and eYFP (white) cohorts shown in
Figure 3. (
c) Fiber tip placement in VM for ChR2 (blue) and eYFP (white) cohorts shown in
Figure 3. (
d) Fiber tip placement in the DRN for ChR2 (blue) and eYFP (white) cohorts shown in
Figure 3. (
e) Fiber tip placement for axonal dMSN stimulation over the cerebral peduncle/anterior SNr (left), and coronal slices from mice infused with saline or FLEx-Caspase three in the DRN showing intact or absent 5HT expression in DRN, respectively (right), from mice used in
Figure 4. (
f) Fiber tip placement in the striatum (left) and infusion site (right) for D1-ChR2 mice infused saline (blue) or muscimol (red) used for self-stimulation or locomotion (grey) assays shown in
Figure 5. (
g) Left: Fiber tip placement for dMSN axonal stimulation over the cerebral peduncle (cp) in vGAT-cre mice infused with DIO-ChR2 in the striatum and DIO-ChR2 (blue) or DIO-eYFP (white) in the SNr, and coronal slice showing eYFP +dMSN fibers and fiber tip. Right: In the same mice, fiber tip placement for SNr terminal stimulation in VM, and coronal slice from a vGAT-Cre mouse infused with DIO-eYFP in the striatum and DIO-mCherry in the SNr, showing segregation of dMSN axons (green) en route to the SNr, and SNr terminals (red) in VM. From mice used in
Figure 5.